↓ Skip to main content

FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer

Overview of attention for article published in Pharmaceutical Research, March 2010
Altmetric Badge

Mentioned by

peer_reviews
1 peer review site

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
27 Mendeley
citeulike
1 CiteULike
Title
FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer
Published in
Pharmaceutical Research, March 2010
DOI 10.1007/s11095-010-0106-x
Pubmed ID
Authors

Zhiwei Wang, Aamir Ahmad, Sanjeev Banerjee, Asfar Azmi, Dejuan Kong, Yiwei Li, Fazlul H. Sarkar

Abstract

Pancreatic cancer remains the fourth most common cause of cancer-related death in the United States. Therefore, novel strategies for the prevention and/or treatment are urgently needed. Genistein has been found to be responsible for lowering the rate of pancreatic cancer. However, the molecular mechanisms by which genistein elicits its effects on pancreatic cancer cells has not been fully elucidated. Therefore, the purpose of the current study was to elucidate the anti-cancer mechanism(s) of genistein.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 4%
Unknown 26 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 33%
Student > Master 6 22%
Student > Bachelor 2 7%
Researcher 2 7%
Student > Postgraduate 2 7%
Other 3 11%
Unknown 3 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 30%
Biochemistry, Genetics and Molecular Biology 7 26%
Medicine and Dentistry 6 22%
Immunology and Microbiology 1 4%
Chemistry 1 4%
Other 0 0%
Unknown 4 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2016.
All research outputs
#15,303,056
of 22,758,963 outputs
Outputs from Pharmaceutical Research
#2,232
of 2,855 outputs
Outputs of similar age
#77,844
of 95,535 outputs
Outputs of similar age from Pharmaceutical Research
#49
of 56 outputs
Altmetric has tracked 22,758,963 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,855 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,535 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.